NIH-funded research Fellowship grant

Understanding the genetics and relapse patterns of Plasmodium ovale malaria in Africa

Official title: Population genomics and relapse epidemiology of Plasmodium ovale in sub-Saharan Africa

Funded at Univ of North Carolina Chapel Hill · NIH-10901459 · Data updated 2026-11-12

This study is looking at how the Plasmodium ovale malaria parasite affects children in Tanzania, especially how it can come back after they’ve been treated, to help us understand more about this type of malaria and how it spreads.

More Relapse research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startAugust 1, 2024
Project endMarch 31, 2028
Funding year2024
Award (this year)$41,012
NIH project number1F30AI179111-01A1
Project IDNIH-10901459 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation are children under 11 years old living in sub-Saharan Africa who have experienced malaria infections.

Less likely to help

Patients who do not reside in sub-Saharan Africa or who are over the age of 11 may not benefit from this research.

What this research studies

This research investigates the genetic makeup and relapse patterns of the Plasmodium ovale malaria parasite, which is increasingly recognized as a significant health concern in sub-Saharan Africa. By analyzing blood samples from children and utilizing advanced molecular techniques, the study aims to uncover how this parasite behaves and spreads, particularly focusing on its ability to cause relapses after initial infections. The research will involve a cohort of Tanzanian participants who have been monitored over time for malaria recurrence, providing valuable insights into the epidemiology of this lesser-known malaria species.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for malaria prevention and treatment, particularly for infections caused by Plasmodium ovale.

How similar studies have gone: While research on Plasmodium falciparum is well-established, studies focusing on Plasmodium ovale are less common, making this approach relatively novel.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Carey-Ewend, Kelly — Univ of North Carolina Chapel Hill
  • Study coordinator: Carey-Ewend, Kelly

Related research

Other NIH-funded projects on the same topics.

  • Social stress and smoking: why disadvantaged young adults struggle to quit

    This grant looks at how daily social stress affects if and when disadvantaged young adults who smoke can quit and stay quit.

    NIH research Medical University of South Carolina · Charleston, United States · NIH-11540695

  • Learning from remission and relapse in lupus (SLE)

    Researchers are studying people with systemic lupus erythematosus who are in long-term remission without steroids or immunosuppressants to understand their immune cells, brain function, and what might predict relapse.

    NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11513534

  • Learning from Remission and Relapse in SLE

    A program to study people with systemic lupus erythematosus who are in long-term remission to understand immune and brain signals that might predict relapse.

    NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11513533

  • Alternative NF-kB activation after chemotherapy in ovarian cancer

    This grant studies how ovarian cancer might come back after chemotherapy by looking at specific signaling pathways in cancer cells and the tumor environment.

    NIH research San Diego State University · San Diego, United States · NIH-11473227

  • Predictors of autoimmunity onset and relapse in skin

    A study to understand what biological signals in skin predict when autoimmune diseases start, flare, or worsen in people at risk.

    NIH research Massachusetts General Hospital · Boston, United States · NIH-11471389

  • Determinants of TB Control, Relapse, and Reinfection

    A large, multi-year study aims to understand why some people who are treated for TB still have persistent infection or relapse, with the goal of improving prevention and treatment.

    NIH research Weill Medical Coll of Cornell Univ · New York, United States · NIH-11449646

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.